Disintegration of GlaxoSmithKline will cost £2,4 billion

GSK could not disprove communication of congenital anomalies with Zofran's reception

The new director general companies is appointed by "EGIS-RUS"

Rustam Minnikhanov met the management of companies GlaxoSmithKline

Rating of daily business newspaper "RBK daily": 25 female-CEO Russian businesses

In New Moscow started production an antivich-preparation of Tivikay for 300 million rubles

For discussion: "Foreign pharmaceutical companies reported about problems with delivery vaccines to Russian Federation"

Foreign pharmaceutical companies reported about problems with delivery vaccines to Russian Federation